Previous Page  21 / 50 Next Page
Information
Show Menu
Previous Page 21 / 50 Next Page
Page Background

Notes:

Page 36

Gastro 2016

August 11-12, 2016

Volume 6, Issue 4(Suppl)

J Gastrointest Dig Syst 2016

ISSN:2161-069X JGDS, an open access journal

conferenceseries

.com

August 11-12, 2016 Birmingham, UK

6

th

Global Gastroenterologists Meeting

Shahira El-Etreby et al., J Gastrointest Dig Syst 2016, 6:4(Suppl)

http://dx.doi.org/10.4172/2161-069X.C1.034

Validation of plasma proteasome as a tumor biomarker for diagnosis of hepatocellular carcinoma

Shahira El-Etreby, Ahmed zaid, Monir Bahgat, Salah Al-Gamal, ManalAbd Elhamid, SherinAbd El-Azi, Hosam Zaghloul, Metwally Mortada, Mohamed

El-Rakhawy

and

Gehan Mazroa

Mansoura University, Egypt

Background & Aim:

Early diagnosis of Hepatocellular Carcinoma (HCC) improves prognosis. While many studies revealed

that alpha-fetoprotein (AFP) is a poor HCC biomarker, more recent studies nominated Plasma Proteasome (PP) as a promising

one. So, our aim is to evaluate diagnostic accuracy of PP level as a tumor biomarker for diagnosis of early HCC in Egyptian

patients with liver cirrhosis and to validate it on a large population.

Methods:

This study enrolled 120 patients with hepatitis C virus related cirrhosis (60 with HCC and 60 without HCC) versus

60 healthy controls. HCC patients were subdivided into 3 groups according to tumor burden. PP level and AFP were assessed.

Then, validation of these results on large number of HCC population (308 cases) was done.

Results:

It was observed that, 200 ng/ml of AFP showed sensitivity for only 40.1%. On the other hand, AUC of PP was 0.883

(0.829-0.938), with cutoff value of 1.1 μg/ml having sensitivity of 98.3%, and specificity of 71.25%. There was no statistically

significant correlation between the level of PP and tumor size, portal invasion or tumor stage (p values = 0.89, 0.07, and 0.82,

respectively). Validation of these results on 308 patients yielded sensitivity of 95.12% and specificity of 60%.

Conclusions:

PP level could be a promising biomarker for early HCC diagnosis in cirrhotic patients.

Biography

Shahira El-Etreby has done her specialization in Internal Medicine in the year 2006. Currently, she is an Assistant Professor in Hepatology and Gastroenterology,

Mansoura University, Egypt.

monirbahgat@gmail.com